8-K: ZyVersa Therapeutics Reports Third Quarter, 2024 Financial Results and Provides Business Update
10-Q: Q3 2024 Earnings Report
10-Q: Q2 2024 Earnings Report
10-Q: Q1 2024 Earnings Report
10-K/A: Annual report (Amendment)
LARKSPUR HEALTH ACQUISITION CORP C/WTS (TO PUR COM) | 8-K: ZyVersa Therapeutics Reports First Quarter 2023 Corporate and Financial Results Key Highlights:
LARKSPUR HEALTH ACQUISITION CORP C/WTS (TO PUR COM) | 8-K: ZyVersa Therapeutics Reports Fourth Quarter and Year-End 2022 Corporate and Financial Results
No Data
No Data